in vivo study Applications
-
Highly customized aptamer discovery solutions for aptamers in neurological disease sector
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Acoustic Bioprinter for Bridging from Bench to Bedside
In vivo evaluation of sound-patterned endothelial cells. ...
By mimiX Biotherapeutics based in Biel/Bienne, SWITZERLAND.
-
Highly customized aptamer discovery solutions for therapeutic aptamers sector
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Highly customized aptamer discovery solutions for drug delivery sector
off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you